2017 Annual Meeting

001 - SESSION 1: Too Thick or Too Thin? Bleeding and Thrombosis in MCS

Apr 5, 2017 2:30pm ‐ Apr 5, 2017 4:00pm


Description

(3) Plasma Free Hemoglobin Activates Platelets and Protects Von Willebrand Factor from Degradation: Clinical and In Vitro Evidence That LVAD Hemolysis Causes LVAD Thrombosis
Carlo Bartoli, MD, PhD

(4) The Effect of Pre-Existing Hypercoagulable Disorders on Outcomes in Patients with LVADs
Sirtaz Adatya, MD

(5) Standard Dose Doxycycline Does Not Alter von Willebrand Factor Degradation in Patients with CF LVAD
Mary Keebler, MD

(6) Platelet Membrane-Related Morphologic Alterations: An Early Marker of Supra-Physiologic Shear-Mediated Platelet Activation Associated with VADs
Marvin J. Slepian, MD

(7) Novel Analysis of High-Molecular-Weight Von Willebrand Factor Multimers Predicts Bleeding Events
Samson Hennessy-Strahs, BA

(8) Managing Anticoagulation in LVAD Patients: The Harefield Experience
Rachel Hards, RGN

Speaker(s):

Tags: MCS NHSAH PHARM HF

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
* - Indicates answer is required.
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content